Slide locked Sign in to view
Slide schematic 6/6
list 3/3 source-note 1/1 title 2/2
Components 6
bullet bullet bullet source-note action-title headline
Tools 0
∅
No tools

No canon tool match is anchored to this slide.

Metrics 1
adoption rate share_penetration · 65%

The widespread adoption of a new class of drugs for preventing stroke is limited despite clinical and cost-effective benefits

Frameworks 0
∅
No frameworks

No framework match is anchored to this slide.